[31-411-pm] Pharmacotherapies (Personalized therapies) 1

Sun. Mar 31, 2024 2:15 PM - 3:15 PM [Room 411] Conference Center 411 (4F)

Chair: Takigawa Masaki, Masayuki Tsujimoto

+Add all to schedule

2:15 PM - 2:27 PM

[31-411-pm06S] Search for endogenous biomarker of CYP3A5 using genome-wide association study and metabolomics-Solid phase extraction with reverse phase-strong anion exchanged mixed mode-

○Nao Yamagishi¹, Yosuke Suzuki¹, Koudai Iino¹, Sakura Suzuki¹, Natsuki Kamio¹, Teruhide Koyama², Ayako Oda¹, Keiko Ohno¹ (1. Meiji Pharmaceutical University, 2. Kyoto Prefectural University of Medicine)

2:27 PM - 2:39 PM

[31-411-pm07S] Search for novel biomarkers of cytochrome P450 2D6 through genome-wide association study and metabolomics -Solid phase extraction by reversed phase-strong anion exchange mixed mode-

○Natsuki Kamio¹, Yosuke Suzuki¹, Koudai Iino¹, Sakura Suzuki¹, Nao Yamagishi¹, Teruhide Koyama², Ayako Oda¹, Keiko Ohno¹ (1. Meiji pharmaceutical university, 2. Kyoto prefectural university of medicine)

2:39 PM - 2:51 PM

[31-411-pm08S] Search for endogenous biomarker of CYP2C19 using genome-wide association study and metabolomics-Solid phase extraction by reversed phase-strong anion exchanged mixed mode-

○Sakura Suzuki¹, Yosuke Suzuki¹, Koudai Iino¹, Nao Yamagishi¹, Natsuki Kamio¹, Teruhide Koyama², Ayako Oda¹, Keiko Ohno¹ (1. Meiji Pharmaceutical University, 2. Kyoto Prefectural University of Medicine)

2:51 PM - 3:03 PM

[31-411-pm09S] Search for novel biomarkers of OATP1B1 activity using genome-wide association study and metabolomics. -Solid phase extraction by reversed phase-strong anion exchange mixed mode-

○Koudai Iino¹, Yosuke Suzuki¹, Sakura Suzuki¹, Nao Yamagishi¹, Natsuki Kamio¹, Ayako Oda¹, Teruhide Koyama², Keiko Ohno¹ (1. Meiji Pharmaceutical University, 2. Kyoto Prefectural University of Medicine)

3:03 PM - 3:15 PM

[31-411-pm10] Measurement of serum Infliximab and Interleukin-6 concentrations predicts continuation of Infliximab treatment in patients with Rheumatoid Arthritis

○Sho Masui^1,2,3, Miyuki Nakamura^2,3, Akira Onishi⁴, Motomu Hashimoto^4,5, Hideo Onizawa⁴, Takayuki Fujii^4,6, Kosaku Murakami⁷, Koichi Murata^4,6, Masao Tanaka⁴, Kotoko Yokoyama⁸, Noriko Iwamoto⁸, Takashi Shimada⁸, Kotaro Itohara², Daiki Hira², Shunsaku Nakagawa², Satoshi Imai², Takayuki Nakagawa², Makoto Hayakari², Shuichi Matsuda⁶, Akio Morinobu^4,9, Tomohiro Terada², Kazuo Matsubara², Atsushi Yonezawa^1,2,3 (1. Sch. Pharm. Sci., Keio Univ., 2. Dept. Pharm., Kyoto Univ. Hospital., 3. Grad. Sch. Pharm. Sci., Kyoto Univ., 4. Center for Rheumatic Diseases, Kyoto Univ. Hospital., 5. Dept. Clin. Immunol., Osaka Metro. Univ. Hospital., 6. Dept. Ortho. Surg., Kyoto Univ. Hospital., 7. Center for Cancer Immunotherapy and Immunobiology, Kyoto Univ. Hospital., 8. Shimadzu Corp., 9. Dept. Rheumatol. & Clin Immunol., Kyoto Univ. Hospital.)

Session information